39 related articles for article (PubMed ID: 31934557)
1. A Risk-adapted Approach to Follow-up in Differentiated Thyroid Cancer.
Tarasova VD; Tuttle RM
Rambam Maimonides Med J; 2016 Jan; 7(1):. PubMed ID: 26886955
[TBL] [Abstract][Full Text] [Related]
2. Session 3 of the RSS Special Topic Meeting on Covid-19 Transmission: Replies to the discussion.
Bekker-Nielsen Dunbar M; Hofmann F; Held L
J R Stat Soc Ser A Stat Soc; 2022 Nov; 185(Suppl 1):S158-S164. PubMed ID: 38607908
[No Abstract] [Full Text] [Related]
3. Prognostic Significance of Thyroglobulin Antibodies in Differentiated Thyroid Cancer.
Reverter JL; Rosas-Allende I; Puig-Jove C; Zafon C; Megia A; Castells I; Pizarro E; Puig-Domingo M; Granada ML
J Thyroid Res; 2020; 2020():8312628. PubMed ID: 32351680
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and outcome of thyroglobulin elevation and negative iodine scintigraphy (TENIS) patients with negative neck ultrasound: Experience from a thyroid carcinoma clinic in India.
Vijayan R; Palaniswamy SS; Vadayath UM; Nair V; Kumar H
World J Nucl Med; 2021; 20(4):361-368. PubMed ID: 35018151
[TBL] [Abstract][Full Text] [Related]
5. Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?
Gajowiec A; Chromik A; Furga K; Skuza A; Gąsior-Perczak D; Walczyk A; Pałyga I; Trybek T; Mikina E; Szymonek M; Gadawska-Juszczyk K; Kuchareczko A; Suligowska A; Jaskulski J; Orłowski P; Chrapek M; Góźdź S; Kowalska A
J Clin Med; 2021 May; 10(11):. PubMed ID: 34072690
[TBL] [Abstract][Full Text] [Related]
6. The effect of the area proportion of the metastatic lesion within the central metastatic lymph node on response to therapy in papillary thyroid carcinoma.
Shi L; Zhou L; Wang J; Jin L; Lei Y; Xia L; Xie L
Oncol Lett; 2021 Apr; 21(4):284. PubMed ID: 33732360
[TBL] [Abstract][Full Text] [Related]
7. Surgical options for thyroid cancer and post-surgical management.
Doubleday A; Sippel RS
Expert Rev Endocrinol Metab; 2018 May; 13(3):137-148. PubMed ID: 30058897
[TBL] [Abstract][Full Text] [Related]
8. Implementing Key Changes in the American Thyroid Association 2015 Thyroid Nodules/Differentiated Thyroid Cancer Guidelines Across Practice Types.
Twining CL; Lupo MA; Tuttle RM
Endocr Pract; 2018 Sep; 24(9):833-840. PubMed ID: 30308136
[TBL] [Abstract][Full Text] [Related]
9. Performance of ATA Risk Stratification Systems, Response to Therapy, and Outcome in an Indian Cohort of Differentiated Thyroid Carcinoma Patients: A Retrospective Study.
Ruben R; Pavithran PV; Menon VU; Nair V; Kumar H
Eur Thyroid J; 2019 Dec; 8(6):312-318. PubMed ID: 31934557
[TBL] [Abstract][Full Text] [Related]
10. Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
Lee SG; Lee WK; Lee HS; Moon J; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS; Lee J
Thyroid; 2017 Feb; 27(2):174-181. PubMed ID: 27750028
[TBL] [Abstract][Full Text] [Related]
11. Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence.
Pitoia F; Jerkovich F; Urciuoli C; Schmidt A; Abelleira E; Bueno F; Cross G; Tuttle RM
Thyroid; 2015 Nov; 25(11):1235-42. PubMed ID: 26132983
[TBL] [Abstract][Full Text] [Related]
12. Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM.
Sapuppo G; Grasso S; Di Benedetto G; Belfiore A; Pellegriti G
Front Endocrinol (Lausanne); 2023; 14():1128963. PubMed ID: 36992807
[TBL] [Abstract][Full Text] [Related]
13. Improving the prediction of persistent and recurrent differentiated thyroid cancer using the American Thyroid Association 2015 risk stratification system.
Markantes GK; Karakioulaki M; Papanikolopoulou S; Theodoropoulou A; Markou KB; Vagenakis AG; Spyridonidis T; Goulis DG; Michalaki MA
Hormones (Athens); 2021 Dec; 20(4):761-768. PubMed ID: 34383288
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
